Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chandreshwar P Thakur

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
European Journal of Immunology|July 19, 2012
Impaired expression of CD26 compromises T-cell recruitment in human visceral leishmaniasisAmbak K Rai, Chandreshwar P Thakur, Prabin Kumar, et al.
The New England Journal of Medicine|June 22, 2007
Injectable paromomycin for Visceral leishmaniasis in IndiaShyam Sundar, T K Jha, Chandreshwar P Thakur, et al.
Acta Parasitologica|July 23, 2016
Increased level of soluble adenosine deaminase in bone marrow of visceral leishmaniasis patients: an inverse relation with parasite loadAmbak K Rai, Prabin Kumar, Sheetal Saini, et al.
The American Journal of Tropical Medicine and Hygiene|December 16, 2005
A phase II dose-ranging study of sitamaquine for the treatment of visceral leishmaniasis in IndiaTara K Jha, Shyam Sundar, Chandreshwar P Thakur, et al.
Journal of Tropical Medicine|December 17, 2011
Phase 4 pharmacovigilance trial of paromomycin injection for the treatment of visceral leishmaniasis in IndiaPrabhat K Sinha, T K Jha, Chandreshwar P Thakur, et al.
Plos One|February 21, 2012
Regulatory T cells suppress T cell activation at the pathologic site of human visceral leishmaniasisAmbak K Rai, Chandreshwar P Thakur, Amar Singh, et al.
Cytokine|June 18, 2025
Leishmania donovani infection-driven high levels of IL-10 causes hypoalbuminemia in human visceral leishmaniasisBharat Singh, Sheetal Saini, Smita Kumari, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
European Journal of Immunology|July 19, 2012
Impaired expression of CD26 compromises T-cell recruitment in human visceral leishmaniasisAmbak K Rai, Chandreshwar P Thakur, Prabin Kumar, et al.
The New England Journal of Medicine|June 22, 2007
Injectable paromomycin for Visceral leishmaniasis in IndiaShyam Sundar, T K Jha, Chandreshwar P Thakur, et al.
Acta Parasitologica|July 23, 2016
Increased level of soluble adenosine deaminase in bone marrow of visceral leishmaniasis patients: an inverse relation with parasite loadAmbak K Rai, Prabin Kumar, Sheetal Saini, et al.
The American Journal of Tropical Medicine and Hygiene|December 16, 2005
A phase II dose-ranging study of sitamaquine for the treatment of visceral leishmaniasis in IndiaTara K Jha, Shyam Sundar, Chandreshwar P Thakur, et al.
Journal of Tropical Medicine|December 17, 2011
Phase 4 pharmacovigilance trial of paromomycin injection for the treatment of visceral leishmaniasis in IndiaPrabhat K Sinha, T K Jha, Chandreshwar P Thakur, et al.
Plos One|February 21, 2012
Regulatory T cells suppress T cell activation at the pathologic site of human visceral leishmaniasisAmbak K Rai, Chandreshwar P Thakur, Amar Singh, et al.
Cytokine|June 18, 2025
Leishmania donovani infection-driven high levels of IL-10 causes hypoalbuminemia in human visceral leishmaniasisBharat Singh, Sheetal Saini, Smita Kumari, et al.
Pageof 1